In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Selfcare buys diabetes products supplier Can-Am for $27mm

Executive Summary

Selfcare (home diagnostics for diabetes, women's health, as well as nutritional supplements) bought Can-Am Care, a supplier of diabetes care products for $27mm--$13.6mm in cash, a $2mm note, and $1.1mm in Selfcare common stock.
Deal Industry
  • Distributors
  • In Vitro Diagnostics
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies